Privia Health Group Inc reports results for the quarter ended in June - Earnings Summary

Privia Health

08/08/2024 14:32

* Privia Health Group Inc  PRVA.OQ  reported quarterly
adjusted
earnings of 3 cents​​ per share for the quarter ended in June,
lower than the same quarter last year, when the company reported
EPS of 6 cents.  The mean expectation of twenty one analysts for
the quarter was for earnings of 5 cents per share. Wall Street
expected results to range from 1 cents to 8 cents per share.
    * Revenue fell 39.7% to $422.33 million from a year ago;
analysts
expected $706.45 million. 
    * Privia Health Group Inc's reported EPS for the quarter was
3
cents​.
    * The company reported quarterly net income of $3.47
million.
    * Privia Health Group Inc shares had risen by 5.1% this
quarter and lost 20.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 16.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 19 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Privia Health
Group Inc is $25.00 
This summary was machine generated from LSEG data August 8 at
01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.05           0.03           Missed
 Mar. 31 2024      0.05           0.02           Missed
 Dec. 31 2023      0.04           0.02           Missed
 Sep. 30 2023      0.05           0.05           Met